Ballesteros Javier, Maeztu Ana I, Callado Luis F, Meana J Javier, Gutiérrez Miguel
University of the Basque Country, Department of Neuroscience, Barrio Sarriena s/n, 48940-Leioa, Spain.
Eur Neuropsychopharmacol. 2008 Jan;18(1):55-61. doi: 10.1016/j.euroneuro.2007.05.001. Epub 2007 Jun 13.
Previous studies have reported negative findings for the association among brain monoamine oxidase B (MAO-B) and suicidal behaviour. However those studies did not adequately control their main results for the influence of confounding variables such as age at death. We have evaluated the association of MAO-B density (assessed by [3H]Ro 19-6327 - lazabemide - binding) with type of death (suicide victims vs non-suicide controls) after controlling for age at death. Frontal cortex samples from 43 subjects (21 suicides, 22 controls) were assayed for MAO-B density at a single concentration of lazabemide (8 nM). A linear regression modelling approach comparing nested models resulted with both type of death (p<0.05) and age of death (p<0.01) as main explanatory variables for the variability of MAO-B density. Suicide victims had >30% more binding sites for lazabemide than controls. Contrary to previous reports, MAO-B density seems to increase in suicide victims.
先前的研究报告了脑单胺氧化酶B(MAO-B)与自杀行为之间关联的阴性结果。然而,这些研究没有充分控制诸如死亡年龄等混杂变量对其主要结果的影响。我们在控制了死亡年龄后,评估了MAO-B密度(通过[3H]Ro 19-6327 - 拉扎贝胺结合法评估)与死亡类型(自杀受害者与非自杀对照组)之间的关联。对43名受试者(21名自杀者,22名对照组)的额叶皮质样本在单一浓度的拉扎贝胺(8 nM)下测定MAO-B密度。采用线性回归建模方法比较嵌套模型,结果显示死亡类型(p<0.05)和死亡年龄(p<0.01)均为MAO-B密度变异性的主要解释变量。自杀受害者的拉扎贝胺结合位点比对照组多30%以上。与先前的报告相反,自杀受害者的MAO-B密度似乎有所增加。